Teladoc (TDOC) director Jacobson gains 30,441 RSUs and 28,986 shares via RSU vesting
Teladoc Health director Catherine Jacobson received a grant of 30,441 restricted stock units (RSUs) on May 21, 2026, which will vest by May 21, 2027. She also exercised 28,986 previously granted RSUs on May 20, 2026, converting them into common shares. Following these transactions, Jacobson holds 66,853 common shares and 30,441 RSUs in Teladoc.
How Teladoc Health Inc. (TDOC) Affects Rotational Strategy Timing
Teladoc Health Inc. (TDOC) exhibits mixed sentiment, with a mid-channel oscillation pattern and an exceptional 68.5:1 risk-reward short setup. The article details institutional trading strategies including long, breakout, and short positions based on AI-generated signals for different time horizons. It suggests choppy conditions due to divergent sentiment across horizons.
Teladoc (NYSE: TDOC) director receives 30,441 RSUs equity award
Teladoc Health (NYSE: TDOC) director Mark Douglas Smith received an equity award of 30,441 restricted stock units (RSUs) as compensation, as reported in a recent Form 4 filing. These RSUs represent a contingent right to receive one share of Teladoc common stock each and will vest in full on the earlier of May 21, 2027, or the day before the company's 2027 annual shareholder meeting. This transaction is a compensation-related grant and not an open-market stock purchase or sale.
[Form 4] Teladoc Health, Inc. Insider Trading Activity
A recent Form 4 filing indicates Teladoc Health, Inc. director Kenneth H. Paulus acquired 30,441 restricted stock units. These units represent a contingent right to receive one share of TDOC common stock each and will vest in full on the earlier of May 21, 2027, or the day before the company's 2027 annual stockholder meeting, with shares delivered upon specific events like separation of service or a change of control. The filing suggests a neutral impact and sentiment regarding this insider transaction.
Teladoc Health (NYSE: TDOC) 2026 meeting backs board, pay and auditor
Teladoc Health's 2026 Annual Meeting of Stockholders saw the election of all nine director nominees, advisory approval of named executive officers' compensation, and the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. All proposals received more votes in favor than against. The company filed an 8-K report detailing the full voting results.
Teladoc Health urges connected care model adoption amid rising mental health quality benchmarks
Teladoc Health is advocating for the widespread adoption of connected care models in mental health, citing increasing policy emphasis on quality benchmarks, particularly CMS's prioritization of NCQA’s Depression Screening and Follow-Up measure. The company believes these models are crucial for meeting elevated standards and has released research showing that frequent engagement in mental health services accelerates recovery for patients with anxiety and depression. Teladoc Health highlighted these points during Mental Health Awareness Month, urging stakeholders to embrace innovative approaches.
BetterHelp Quality Push Puts Teladoc Mental Health Story In Focus
BetterHelp, a subsidiary of Teladoc Health, has partnered with the Institute of Patient Safety and Quality of Virtual Care to enhance patient safety and clinical quality in virtual mental health services. This initiative, while potentially adding costs, aims to improve Teladoc's mental health offerings, appealing to insurers and employers, and could be a crucial factor for investors given Teladoc's past stock volatility and recent sales stagnation. The partnership's success will be measured by its impact on incident rates, patient satisfaction, and payer relationships, potentially helping BetterHelp transition towards a more stable, insurance-based revenue model.
Three Small-Cap Stocks Facing Headwinds
This article identifies three small-cap stocks—Teladoc Health (TDOC), Global Business Travel Group (GBTG), and Clean Energy Fuels (CLNE)—that are experiencing headwinds and might be best avoided by investors. The analysis, based on a StockStory report, cites stagnating sales, declining customer spending, high servicing costs, and slower-than-peer revenue growth as key concerns for these companies. Each company's market capitalization, financial performance, and specific challenges are detailed.
BetterHelp Quality Push Puts Teladoc Mental Health Story In Focus
Teladoc Health's subsidiary, BetterHelp, is collaborating with the Institute of Patient Safety and Quality of Virtual Care to enhance patient safety and quality in virtual mental health services through data insights. This initiative aims to improve clinical oversight and reliability, which could be crucial for Teladoc, given its recent share price volatility and flat sales. While it may increase costs, the partnership could help transition BetterHelp into a more payer-friendly platform, potentially improving its appeal to insurers and large organizations.
Teladoc Health, Inc. (NYSE:TDOC) Receives Average Rating of "Hold" from Analysts
Teladoc Health, Inc. (NYSE:TDOC) has received an average "Hold" rating from 18 analysts, with a target price of approximately $7.53, according to MarketBeat Ratings. The company continues to face profitability challenges, reporting a quarterly loss and a revenue decline, and has issued guidance predicting further losses for FY2026 and Q2 2026. Recent analyst actions have been mixed, including some upgrades to "Buy" and several price target reductions with "Hold" or "Equal Weight" ratings.
Millions use BetterHelp for therapy. New safety push targets virtual care risks
BetterHelp, the world's largest online therapy platform and a subsidiary of Teladoc Health, has partnered with the Institute of Patient Safety and Quality of Virtual Care. This collaboration aims to enhance safety and quality in virtual mental health care by improving data analysis, risk identification, and continuous improvement processes. By joining this federally recognized Patient Safety Organization (PSO), BetterHelp seeks to strengthen clinical standards, advance outcomes, and support scalable growth in virtual care delivery.
Teladoc Health partners with Davids Bridal to deliver personalized virtual health support for workforce
Teladoc Health has partnered with Davids Bridal to provide personalized virtual health support to its workforce, emphasizing improved employee well-being, engagement, and measurable health outcomes. This collaboration was announced during Women's Health Week and leverages Teladoc's virtual care solutions. Teladoc's research highlights the effectiveness of frequent mental health service engagement in recovery from anxiety and depression, and the company is also expanding its virtual primary care offerings to reduce healthcare costs and improve access.
Vanguard Group Inc. Decreases Position in Teladoc Health, Inc. $TDOC
Vanguard Group Inc. has slightly reduced its stake in Teladoc Health, Inc. by 1.9% in the fourth quarter, although it still holds a significant 21.5 million shares. Teladoc's recent quarterly results showed an EPS of -$0.36, missing expectations, and revenue of $613.85 million, which was slightly above estimates but down 2.5% year-over-year. Despite mixed analyst sentiment with a "Hold" consensus rating, other institutional investors have increased their positions in the company, and an insider transaction saw the CEO selling a portion of his shares.
TDOC Q1 earnings miss, revenues down Y/Y on BetterHelp weakness
Teladoc Health (TDOC) reported a Q1 earnings miss and a year-over-year revenue decline, primarily attributed to weaker performance in its BetterHelp segment. Despite the revenue challenges, the company reiterated its full-year guidance.
Teladoc Health (TDOC) Is Up 14.9% After Narrower Q1 Loss And Cautious 2026 Outlook – What's Changed
Teladoc Health (TDOC) reported a narrower Q1 2026 loss with sales of US$613.85 million, but issued cautious 2026 revenue guidance due to ongoing pressure in its BetterHelp unit. Despite wider-than-expected adjusted losses, the company's long-term investment thesis remains, focusing on profitability improvements in Integrated Care and cost efficiencies. The article discusses how analyst forecasts vary significantly regarding Teladoc's future profitability.
$Teladoc Health (TDOC.US)$ slow wait for profit... goodbye.....
An investor, "The Echo," shared a post on the Moomoo Community expressing their disappointment with Teladoc Health (TDOC.US) due to its slow progress towards profitability, implicitly indicating they are moving on from the investment. The post is a brief personal sentiment rather than an in-depth analysis. It reflects a common concern among investors regarding the prolonged wait for returns from growth companies.
Teladoc Health (TDOC) Is Up 14.9% After Narrower Q1 Loss And Cautious 2026 Outlook – What's Changed
Teladoc Health reported a narrower Q1 2026 net loss of US$63.84 million and an improved loss per share of US$0.36, despite a slight year-over-year revenue decline. The company issued cautious 2026 revenue guidance, citing continued pressure in its BetterHelp mental health unit, which is shifting towards lower-margin insurance revenue. The article emphasizes that while the cautious outlook and wider adjusted loss reinforce existing investment risks, they do not fundamentally alter the long-term thesis that Teladoc can scale virtual care profitably.
Citi Maintains Teladoc Health(TDOC.US) With Hold Rating, Raises Target Price to $7
Citi has maintained a Hold rating on Teladoc Health (TDOC.US) and increased its target price to $7. This adjustment reflects the firm's updated outlook for the company, indicating a cautious but slightly more optimistic view on its stock performance.
Virtual care accelerates accessibility as Teladoc Health, Inc. targets improved outcomes
Teladoc Health, Inc. is actively expanding its virtual primary care initiatives to enhance healthcare access and reduce costs. The company recently highlighted the benefits of meeting patients where they are during a conference in San Diego, aiming to improve outcomes for both employers and individuals. Teladoc is also integrating virtual primary, chronic, and mental health services to offer wider, more flexible, and cost-effective healthcare solutions.
A Look At Teladoc Health (TDOC) Valuation After BetterHelp Insurance Shift And Mixed Q1 Results
Teladoc Health (TDOC) is experiencing renewed investor interest following its Q1 2026 results and a strategic shift in BetterHelp's insurance coverage. Despite a recent rebound in share price, the stock remains significantly below its multi-year highs, prompting questions about whether its current valuation represents a reset entry point or if future growth is already priced in. Simply Wall St's analysis suggests Teladoc is modestly undervalued with a fair value of $7.12, based on conservative growth expectations and assumptions about its Integrated Care execution and BetterHelp's transition.
Ehealth Market is Going to Booming Growth 2026-2033| Teladoc Health, Amwell, Cerner Corporation
The report by Coherent Market Insights analyzes the Ehealth Market from 2026 to 2033, featuring key players like Teladoc Health, Amwell, and Cerner Corporation. It provides detailed insights into market dynamics, competitive landscape, regional performance, and growth opportunities through segmentation analysis and competitive benchmarking. The study aims to equip stakeholders with actionable intelligence for strategic decision-making in the evolving eHealth sector.
Earnings snapshot: Teladoc Health issues weak Q2 revenue outlook after mixed Q1 results
Teladoc Health (TDOC) reported mixed Q1 results, with revenue rising but net loss attributable to the company increasing. The company provided a weak Q2 revenue outlook, forecasting a range of $635 million to $645 million, below analyst estimates, but reaffirmed its full-year revenue guidance.
TDOC Q1 Earnings Miss, Revenues Down Y/Y on BetterHelp Weakness
Teladoc Health (TDOC) reported a first-quarter 2026 adjusted loss of 36 cents per share, missing consensus estimates, and revenues declined 2% year over year to $613.8 million due to weakness in its BetterHelp segment and decreasing subscription revenues. Despite the overall decline, the Integrated Care segment showed growth, and international revenues increased. The company also provided its outlook for Q2 and the full year 2026, anticipating continued challenges for BetterHelp but some growth in Integrated Care.
Is It Time To Reconsider Teladoc Health (TDOC) After The Recent Share Price Rebound?
Teladoc Health (TDOC) has seen recent share price rebounds of 12.3% over 7 days and 22.6% over 30 days, despite multi-year losses. A Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 46.5%, implying an intrinsic value of US$12.07 per share compared to its current price of US$6.46. Additionally, its Price/Sales ratio of 0.46x is significantly below the industry average, further indicating undervaluation.
Is It Time To Reconsider Teladoc Health (TDOC) After The Recent Share Price Rebound?
Teladoc Health (TDOC) has seen a recent share price rebound, with returns of 12.3% over 7 days and 22.6% over 30 days, despite multi-year losses. A Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 46.5%, with an estimated intrinsic value of US$12.07 per share compared to its current price of US$6.46. The article also presents bull and bear case narratives for Teladoc, with fair values ranging from US$5.00 to US$10.50 per share, based on different assumptions about revenue growth, market conditions, and profitability.
Teladoc Health Q1 2026: Revenue Beats Estimates Despite Year-Over-Year Decline
Teladoc Health reported Q1 2026 results, exceeding revenue estimates at $613.8 million despite a 2.5% year-over-year decline. The company's adjusted EBITDA surpassed projections, and it reconfirmed full-year revenue and GAAP EPS guidance, while Q2 guidance came in below expectations. Management attributed performance and future guidance to a shift towards visit-based models, expanded insurance coverage for BetterHelp, and leveraging AI for efficiency and product enhancement.
TDOC SEC Filings - Teladoc Health Inc 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Teladoc Health (TDOC) SEC filings, including annual 10-K reports, quarterly 10-Q reports, 8-K material event filings, and insider trading forms. It highlights recent 8-K filings concerning financial results, credit facilities, and leadership changes, and features an AI-powered summary of a recent Form 4 insider filing detailing Jason Evans' RSU conversion. The platform offers AI-generated summaries, impact scoring, and sentiment analysis for all 73 tracked TDOC filings.
Teladoc Health (NYSE:TDOC) Stock Price Up 7.7% - Here's Why
Teladoc Health (NYSE:TDOC) saw its stock price climb 7.7% on Friday, potentially driven by unusually large call option buying and a narrower Q1 GAAP loss. Despite this, the company reported a slight revenue beat but missed EPS estimates and lowered future guidance, leading to divided Wall Street sentiment and several analyst target cuts. The company's market capitalization is approximately $1.16 billion, with an average "Hold" rating from analysts.
Analysts Are Bullish on These Healthcare Stocks: Teladoc (TDOC), Pfizer (PFE)
Three analysts have issued bullish sentiments on several healthcare stocks, including Teladoc (TDOC) and Pfizer (PFE). Richard Close from Canaccord Genuity maintained a Buy rating on Teladoc with a $10.00 price target, while Guggenheim analysts Vamil Divan and Yatin Suneja reiterated Buy ratings on Pfizer and Biogen (BIIB) with price targets of $36.00 and $260.00 respectively. The article highlights the analysts' track records and the consensus price targets for each company.
HIMS vs. TDOC: Which Digital Health Stock Offers Better Upside Now?
This article compares Hims & Hers Health (HIMS) and Teladoc Health (TDOC), two digital health companies with distinct business models, to determine which offers better upside potential. HIMS focuses on consumer-centric telehealth and personalized treatments, while TDOC provides a comprehensive virtual care platform for employers and health systems. Despite TDOC's recent stock outperformance, the analysis suggests HIMS currently offers relatively better upside due to its growth trajectory and favorable risk-reward balance.
Earnings Call Summary | Teladoc Health(TDOC.US) Q1 2026 Earnings Conference
This document is an earnings call summary for Teladoc Health (TDOC.US) for their Q1 2026 earnings conference. Further details about the financial performance, key highlights, or future outlook are not provided in this entry. The document serves as a record of the earnings event.
Teladoc Health (NYSE: TDOC) Q1 2026 revenue dips as loss narrows
Teladoc Health reported a 2% year-over-year revenue decrease to $613.8 million in Q1 2026, while its net loss narrowed significantly from $93.0 million to $63.8 million, primarily due to the absence of a prior goodwill impairment charge. The company reaffirmed its full-year 2026 financial outlook, anticipating revenue between $2.48 billion and $2.58 billion and positive free cash flow. Integrated Care segment revenue grew, but BetterHelp revenue declined, reflecting mixed performance across its services.
How Teladoc’s Slower Revenue but Narrower Losses Will Impact Teladoc Health (TDOC) Investors
Teladoc Health (TDOC) recently released its first-quarter 2026 results, showing a slight decrease in revenue to US$613.85 million but a narrower net loss of US$63.84 million. This suggests the company is improving cost control and efficiency despite softening top-line growth. Investors should watch if Teladoc can maintain cost discipline while stabilizing growth, especially with its BetterHelp platform and new initiatives like enhanced 24/7 Care.
(TDOC) Teladoc Health, Inc. Expects Q2 Revenue Range $597.0M - $626.0M
Teladoc Health, Inc. announced its Q2 revenue expectations, projecting a range of $597.0 million to $626.0 million. This follows their Q1 revenue report of $613.8 million, surpassing FactSet estimates. The company, which provides virtual healthcare services including general medical, chronic condition management, and mental health, continues to release financial updates and leadership changes.
Teladoc Health, Inc. reports first quarter 2026 earnings release
Teladoc Health, Inc. has announced its financial results for the first quarter of 2026, providing key performance details for the telemedicine provider. Investors and analysts are closely scrutinizing these results amidst a competitive digital healthcare market. The company has recently expanded its offerings to include dietitian-led nutrition services and proposed a virtual care model to replace annual urgent care visits, as part of a broader strategic effort.
Teladoc Health Reports First Quarter 2026 Results
Teladoc Health reported first quarter 2026 results, with total revenue of $613.8 million, a 2% decrease year-over-year, and a net loss of $63.8 million. The Integrated Care segment saw a 2% revenue increase, while the BetterHelp segment experienced a 9% decline. The company reaffirmed its full-year financial outlook and highlighted ongoing investments in product innovation, technology, and clinical models to drive future growth.
Teladoc Health reports strong momentum behind BetterHelp insurance shift, CEO says
Teladoc Health's Q1 revenue dipped 2% year-over-year, but the company remains positive about its full-year outlook. CEO Chuck Divita highlighted strong momentum in integrating insurance coverage for its BetterHelp mental health business, which he sees as a significant catalyst for future growth and a turnaround for the segment. This strategic shift, including the acquisition of UpLift, has led to increased session engagement compared to cash-pay models, with insurance-covered sessions now averaging 14,000 per week.
Teladoc faces earnings test as revenue decline looms By Investing.com
Teladoc (TDOC) is facing a critical earnings test with analysts expecting a sequential revenue decline and widening losses for its first-quarter results. The company is battling increased competition and post-pandemic headwinds, with its shares having fallen significantly over the past year. Investors will be watching for stabilization in revenue, progress on cost discipline, and updates on the BetterHelp segment's pivot to insurance reimbursement.
Global Telemedicine & Digital Health Market to Reach USD 180 Billion by 2031, Led by Teladoc, Amwell, and Healthcare Tech Giants
The global Telemedicine & Digital Health market is projected to reach nearly USD 180 billion by 2031, growing from USD 85.50 billion in 2025 at a CAGR of 13.21%. This growth is driven by advancements in AI and ML, expanding digital infrastructure like 4G/5G networks, and the increasing adoption of Remote Patient Monitoring (RPM). North America currently leads the market due to its advanced healthcare infrastructure and supportive regulatory environment.
Why employer healthcare strategies need a rethink | Teladoc Health
This article examines the increasing need for employers to rethink their healthcare strategies due to rising economic inactivity, long NHS waiting lists, and growing absence levels. It highlights findings from the Keep Britain Working Review, discussing how traditional benefit models often fall short in addressing the diverse and evolving health needs of employees, particularly in preventive care and equity of access. The author argues that employers should view healthcare as an investment in workforce resilience, focusing on early intervention and flexible support tailored to different life stages.
Investment Opportunities in Teladoc and PayPal
Teladoc Health (TDOC) faces significant challenges including stagnant visit growth due to competition and a shift to in-person care, resulting in an over 80% stock price decline and ongoing profitability issues despite international growth. In contrast, PayPal (PYPL) shows strong competitive edge with 439 million active accounts and $1.79 trillion total payment volume in 2025, and is expanding into digital advertising to leverage consumer data for future revenue and earnings growth. Analysts have mixed views on TDOC, with some maintaining a "Hold" rating while others downgrade it.
A Look At Teladoc Health (TDOC) Valuation As Activist Buyback Push And AI Partnership Draw Focus
Activist investor Pineal Capital Management is pressuring Teladoc Health to implement at least US$200 million in share buybacks and consider separating its Integrated Care and BetterHelp businesses. This comes as Teladoc partners with Microsoft on AI-powered safety features, intensifying scrutiny on its capital allocation and product strategy. Despite a five-year total shareholder loss, Teladoc's fair value is estimated at $7.12, suggesting it is undervalued, focusing attention on its ability to execute on product innovation and margin improvements.
Rural virtual care delivers equal health improvements, Teladoc Health, Inc.
Teladoc Health Inc. reports that virtual care is effectively closing the healthcare access gap between rural and urban areas, with rural patients showing similar rates of enrollment, engagement, and improved health outcomes as their urban counterparts. This indicates the significant potential of telemedicine in fostering health equity across various geographic locations. The company continues to expand its virtual healthcare offerings, including dietitian-led nutrition programs and advocacy for virtual care over urgent care visits to reduce costs and improve engagement.
A Look At Teladoc Health (TDOC) Valuation As Activist Buyback Push And AI Partnership Draw Focus
Activist investor Pineal Capital Management is urging Teladoc Health (TDOC) to initiate share buybacks worth at least US$200 million and consider separating its Integrated Care and BetterHelp divisions. This push coincides with Teladoc's collaboration with Microsoft on AI-powered safety features, bringing the company's capital allocation and product strategy under investor scrutiny. The article highlights Teladoc's "undervalued" status with a fair value of $7.12 against a current trading price of $5.92, suggesting a potential reset opportunity despite a history of weak long-term performance.
Teladoc Health acquires UpLift, expanding access to mental health care services
This article announces that Teladoc Health has acquired UpLift. This acquisition is set to expand access to mental health care services, integrating UpLift's capabilities into Teladoc's existing platform. The move is aimed at enhancing Teladoc's offerings in the growing telehealth mental health sector.
Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Recommendation of "Hold" from Analysts
Teladoc Health, Inc. (NYSE:TDOC) has received a consensus "Hold" recommendation from analysts, with an average 12-month price target of $7.62. While the company modestly surpassed Q4 earnings estimates, it remains unprofitable, and its CEO recently sold shares. Institutional investors hold a significant portion of the stock, with several increasing their positions.
Teladoc Health (TDOC) Projected to Post Earnings on Wednesday
Teladoc Health (TDOC) is projected to release its Q1 2026 earnings after market close on Wednesday, April 29th, with analysts expecting an EPS of ($0.3412) and revenue of $613.82 million. The company's stock currently trades around $6.00 with a market capitalization of $1.08 billion, and institutional investors own approximately 76.82% of the shares. Analysts generally hold a "Hold" rating for TDOC, with an average price target of $7.62.
Teladoc Health advances AI strategy to prioritize care teams over pure technology
Teladoc Health is actively progressing its AI strategy, focusing on empowering care teams rather than solely relying on technology. The company leverages AI to improve health outcomes for large populations and supports value-based care through digital innovation. This approach includes dietitian-led nutrition services and a virtual care model to replace annual urgent care visits with continuous remote support, aiming to enhance patient engagement and health outcomes.
Is Teladoc (TDOC) Prioritizing Buybacks Over Innovation in Its Virtual Care Strategy?
Activist investor Pineal Capital Management is urging Teladoc Health (TDOC) to authorize a US$200 million share buyback and consider separating its business segments, while Teladoc simultaneously rolls out AI-enabled healthcare solutions. This situation highlights a key debate within the virtual care sector: how to balance immediate capital returns and efficiency with long-term innovation. The article discusses Teladoc's investment narrative, including its AI initiatives and financial forecasts, and encourages investors to examine the data and form their own conclusions.
Is Teladoc (TDOC) Prioritizing Buybacks Over Innovation in Its Virtual Care Strategy?
Activist investor Pineal Capital Management is urging Teladoc Health (TDOC) to authorize a US$200 million share repurchase and consider splitting its business segments, while Teladoc simultaneously integrates AI into its healthcare solutions. This situation highlights the tension between capital efficiency demanded by investors and the long-term innovation Teladoc pursues in the virtual care market. The article discusses how this pressure could influence Teladoc's investment narrative, especially given its current loss-making status and future revenue and earnings projections.
